Your browser doesn't support javascript.
loading
A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.
Blom, Dirk J; Hala, Tomas; Bolognese, Michael; Lillestol, Michael J; Toth, Phillip D; Burgess, Lesley; Ceska, Richard; Roth, Eli; Koren, Michael J; Ballantyne, Christie M; Monsalvo, Maria Laura; Tsirtsonis, Kate; Kim, Jae B; Scott, Rob; Wasserman, Scott M; Stein, Evan A.
Afiliação
  • Blom DJ; From the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.), and TREAD Research, Cardiology Unit, Department of Internal Medicine, Tygerberg Hospital and Stellenbosch University, Parow (L.B.) - both in South Africa; Center for Clinical and Basic Research, Pardubice (T.H.), and Center of Preventive Cardiology, Third Department of Internal Medicine, Charles University, Prague (R.C.) - both in the Czech Republic; Bethesda Health Research Center, Bethesda, MD
N Engl J Med ; 370(19): 1809-19, 2014 May 08.
Article em En | MEDLINE | ID: mdl-24678979
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Proteína Convertases / Hiperlipidemias / LDL-Colesterol / Anticorpos Monoclonais Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Proteína Convertases / Hiperlipidemias / LDL-Colesterol / Anticorpos Monoclonais Idioma: En Ano de publicação: 2014 Tipo de documento: Article